GeneCentric to Present Data on Fragmentomics-Based ExpressCT™ Liquid Biopsy Technology at AACR 2026DURHAM, N.C., April 14, 2026 (GLOBE NEWSWIRE) -- GeneCentric, a company making precision medicine more precise by bringing gene expression biology to liquid biopsy, today announced that it will present three posters at the American Association for Cancer Research (AACR) Annual Meeting 2026 taking place in San Diego, California from April 17-22. The company will also participate in the Myriad Genetics Spotlight Theater (“Advances in ctDNA Testing towards Biopharma Development & Clinical Dx”) and Discovery Life Sciences Flash Talk during the meeting.
